CompaniesByCap
CRSP
Crispr Therapeutics AG (CRSP)
NASDAQ · Healthcare

Crispr Therapeutics AG Cash Flow 2015–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Operating Activities
Operating Cash Flow-345.0M-142.8M-260.4M-495.7M539.0M-238.4M56.7M-96.2M-70.1M-52.9M
Depreciation & Amort.19.5M19.3M19.8M24.2M18.0M9.2M4.7M3.5M3.0M925,000
Investing Activities
Capital Expenditure914,0001.9M9.5M37.2M81.7M18.4M6.7M2.8M7.8M3.0M
Free Cash Flow-345.9M-144.7M-269.8M-532.9M457.3M-256.7M50.0M-99.0M-77.9M-55.9M
Financing Activities
Dividends Paid
Stock Buybacks57,000

Crispr Therapeutics AG Cash Flow — FAQ

Crispr Therapeutics AG (CRSP) cash flow over the last 11 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see CRSP's cash flow history?

The chart and table above show Crispr Therapeutics AG's cash flow by year and by quarter, including the growth rate.